Related Experiment Video
Updated: Jun 14, 2026

07:48
Coculture System with an Organotypic Brain Slice and 3D Spheroid of Carcinoma Cells
Published on: October 9, 2013
Clinging carcinoma: an American perspective
1Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. sschnitt@bidmc.harvard.edu
Seminars in Diagnostic Pathology
|March 24, 2010
Summary
Professor Azzopardi's "clinging carcinoma" concept is validated. Recent studies confirm his second type, now called flat epithelial atypia, is an early stage of ductal carcinoma in-situ (DCIS).
Area of Science:
- Pathology
- Oncology
- Breast Cancer Research
Background:
- Professor John Azzopardi coined "clinging carcinoma" in 1979 for specific ductal carcinoma in-situ (DCIS) presentations.
- Azzopardi described two types: the first, widely accepted as high-grade DCIS; the second, less accepted, particularly in the US.
- The second type features low-grade, monomorphic cells, resembling low-grade DCIS with various architectural patterns.
Purpose of the Study:
- To re-evaluate Azzopardi's second type of clinging carcinoma.
- To determine if this lesion represents a precursor or early stage of ductal carcinoma in-situ (DCIS).
- To validate Azzopardi's original histological observations through modern research.
Main Methods:
- Morphological analysis of the lesion.
- Immunophenotypic studies.
- Genetic analysis.
Main Results:
- Recent studies provide strong evidence supporting Azzopardi's second type of clinging carcinoma.
- This lesion is now commonly referred to as flat epithelial atypia.
- The findings indicate flat epithelial atypia is a precursor or early stage of DCIS.
Conclusions:
- Azzopardi's classification of clinging carcinoma, particularly the second type, is validated by contemporary research.
- Flat epithelial atypia is recognized as an early developmental stage of ductal carcinoma in-situ (DCIS).
- This research underscores the importance of Azzopardi's early histological insights in breast cancer pathology.
Related Concept Videos
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...

